stock
SAEN · Genenta Science S.p.A.
Follow SAEN freePrice
Loading the SAEN chart…
Chart by TradingView
The business
What the company does and what it reports, from its SEC filings.
What it is
No 10-K on file. Funds and foreign issuers don't file one.
- Sector
- Life Sciences (SEC office)
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Headquarters
- Milan, L6
- Incorporated in
- Italy
- Exchange
- Nasdaq
- Fractional shares
- No
- Listed options
- No
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Formerly
- Genenta Science S.r.l. (until 2021)
- Shares outstanding
- 23,432,183 as of Dec 31, 2025 (XBRL frame CY2025Q4I)
- Filer (SEC EDGAR)
- EDGAR filing index
Key stats
Valuation and the ratios that use the live price are free with an account.
Start free to see thisDeep value
- NCAV
- —
- NCAV per share
- —
- NNWC
- —
- NNWC per share
- —
Expectations
- Free cash flow, FY2025
- -6.88M EUR
- Free cash growth, last 5 years
- —
- Revenue growth, last 5 years
- —
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -29.9%
- ROA
- -20.5%
Health
- Current ratio
- 14.2x
- Debt/equity
- —
Fiscal year to Dec 31, 2025; balance sheet at Dec 31, 2025.
Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
No quarterly results reported by SEC for this filer.
- Cash
- 5.53M EUR
- Debt
- —
- Net cash
- —
- Current assets
- 29.98M EUR
- Current liabilities
- 2.12M EUR
- Working capital
- 27.86M EUR
- Total liabilities (not reported by this company)
- —Total liabilities: unreported by this company.
- Assets
- 31.89M EUR
- Equity
- 21.84M EUR
Balance as of Dec 31, 2025.
SEC data as of Nov 17, 2026
Earnings moves
No results filings
Ten years
No revenue reported in these years.
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | -6.60M EUR | -6.53M EUR | -6.88M EUR |
| Dec 31, 2024 | — | -9.76M EUR | -8.91M EUR | -6.24M EUR |
| Dec 31, 2023 | — | -11.73M EUR | -11.65M EUR | -11.22M EUR |
| Dec 31, 2022 | — | -11.04M EUR | -8.48M EUR | -7.45M EUR |
| Dec 31, 2021 | — | -5.69M EUR | -5.53M EUR | -6.97M EUR |
| Dec 31, 2020 | — | -5.59M EUR | -5.59M EUR | -6.07M EUR |
| Dec 31, 2019 | — | -4.62M EUR | -4.60M EUR | — |
What it filed
Material events and 5% ownership filings from the last year.
Company filings
1 offering filing in 12 months
5% owners ()
Marco Nuzzo
Stake update
Marco Nuzzo
Activist stake
Pierluigi Paracchi
Stake update
Owners and trading
Insider, politician and fund moves, short interest, and the volume traded off the exchange.
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
Short interest
Hard to borrow: Alpaca will not lend it for shorting
Off-exchange short volume, 20 days
21.9%
Through Nov 17, 2026
Of the volume reported to FINRA's off-exchange facilities, market makers' hedging included. It is not short interest.
Short interest and short volume: FINRA
Off-exchange and dark pools
No off-exchange data
Members see
- Signals: which strategies fired on SAEN, and the evidence behind each
- Options positioning: the levels dealers are hedged around
- Technicals: trend and momentum readings
- Earnings moves: how the price moved after each report
- News: stories counted once across outlets
nakagai
Signals on SAEN come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Follow SAEN free
Comments · 0
No comments yet.